Discover how NeoVessel™ repairs and regenerates vascular tissue
Unlike current synthetic vascular grafts which stay in the body and can cause potential future vascular blockage, NeoVessel™ is a bioabsorbable scaffold and will only leave newly developed vascular tissue in the body.
Normal blood flow
NeoVessel has bio-resorbed, leaving vessel clear with normal blood flow
NeoVessel™ vs Synthetic Graft and Stint
Over 60% of Graft failure occurs in just 3 years.
12-18 MONTHS POST-OP
News & Updates
San Antonio — Medical device maker Cardiovate has closed a $1 million seed round of funding from an existing group of investors to help it
San Antonio — An early stage San Antonio startup that aims to repair or replace clogged arteries with regenerated tissue has closed a small financing round from angel investors, The University of Texas Horizon Fund, and Targeted Technology, according to its CEO.
12500 Network Blvd Suite 310
San Antonio, Texas 78249
Research & Development
2500 Crosspark Rd. E-141 Coralville, IA 52241
© Copyright 2017 Cardiovate, Inc. All Rights Reserved.